CMS Seeking ‘Collaborative’ Response To Part B Payment Model – Slavitt Tells PhRMA
This article was originally published in The Pink Sheet Daily
Executive Summary
At the trade group's annual meeting, the CMS acting chief urges industry to engage constructively in developing new payment models for Part B drugs and not focus on obstructing any change at all.